157 related articles for article (PubMed ID: 27106176)
1. Effects of Food and Pharmaceutical Formulation on Desmopressin Pharmacokinetics in Children.
Michelet R; Dossche L; De Bruyne P; Colin P; Boussery K; Vande Walle J; Van Bocxlaer J; Vermeulen A
Clin Pharmacokinet; 2016 Sep; 55(9):1159-70. PubMed ID: 27106176
[TBL] [Abstract][Full Text] [Related]
2. Claiming desmopressin therapeutic equivalence in children requires pediatric data: a population PKPD analysis.
Michelet R; Dossche L; Van Herzeele C; Van Bocxlaer J; Vermeulen A; Vande Walle J;
Eur J Clin Pharmacol; 2018 Mar; 74(3):297-305. PubMed ID: 29198064
[TBL] [Abstract][Full Text] [Related]
3. An Integrated Paediatric Population PK/PD Analysis of dDAVP: How do PK Differences Translate to Clinical Outcomes?
Michelet R; Dossche L; Van Herzeele C; De Bruyne P; Gasthuys E; Van Bocxlaer J; Vande Walle J; Vermeulen A
Clin Pharmacokinet; 2020 Jan; 59(1):81-96. PubMed ID: 31347012
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of desmopressin administered as tablet and oral lyophilisate formulation in children with monosymptomatic nocturnal enuresis.
De Bruyne P; De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
Eur J Pediatr; 2014 Feb; 173(2):223-8. PubMed ID: 23989967
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety profile of desmopressin oral tablet formulations in healthy Chinese subjects under fasting and fed conditions.
Li X; Zhang H; Zhu X; Li C; Chen H; Liu J; Chen G; Wu M; Liu C; Shen Z; Niu J; Liu B; Ding Y
Int J Clin Pharmacol Ther; 2018 Sep; 56(9):434-442. PubMed ID: 30049304
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin oral lyophilisate in young children: new insights in pharmacokinetics and pharmacodynamics.
Dossche L; Michelet R; De Bruyne P; Van Herzeele C; Gasthuys E; Rittig S; Vermeulen A; Vande Walle J
Arch Dis Child; 2021 Jun; 106(6):597-602. PubMed ID: 32737054
[TBL] [Abstract][Full Text] [Related]
7. Oral lyophylizate formulation of desmopressin: superior pharmacodynamics compared to tablet due to low food interaction.
De Guchtenaere A; Van Herzeele C; Raes A; Dehoorne J; Hoebeke P; Van Laecke E; Vande Walle J
J Urol; 2011 Jun; 185(6):2308-13. PubMed ID: 21511277
[TBL] [Abstract][Full Text] [Related]
8. A randomised comparison of oral desmopressin lyophilisate (MELT) and tablet formulations in children and adolescents with primary nocturnal enuresis.
Lottmann H; Froeling F; Alloussi S; El-Radhi AS; Rittig S; Riis A; Persson BE
Int J Clin Pract; 2007 Sep; 61(9):1454-60. PubMed ID: 17655682
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis and healthy adults.
Osterberg O; Savic RM; Karlsson MO; Simonsson US; Nørgaard JP; Walle JV; Agersø H
J Clin Pharmacol; 2006 Oct; 46(10):1204-11. PubMed ID: 16988210
[TBL] [Abstract][Full Text] [Related]
10. [Comparison of two sublingual types of desmopressin in 6-year-old and more children with primary nocturnal enuresis. About an international randomized cross-over study].
Lottmann H
Prog Urol; 2009 Feb; 19(2):132-8. PubMed ID: 19168019
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Pharmacology of Desmopressin in Children with Enuresis: A Comprehensive Review.
Gasthuys E; Dossche L; Michelet R; Nørgaard JP; Devreese M; Croubels S; Vermeulen A; Van Bocxlaer J; Walle JV
Paediatr Drugs; 2020 Aug; 22(4):369-383. PubMed ID: 32507959
[TBL] [Abstract][Full Text] [Related]
12. A bioequivalence study of two oral desmopressin tablet formulations.
Kaehler ST; Steiner IM; Sauermann R; Scheidl H; Mueller M; Joukhadar C
Pharmacology; 2006; 77(1):46-52. PubMed ID: 16651830
[TBL] [Abstract][Full Text] [Related]
13. Focus on desmopressin and enuresis: a review of literature.
Ferrara P; Vena F; Basile MC; Ianniello F; Gatto A
Minerva Urol Nefrol; 2016 Feb; 68(1):14-9. PubMed ID: 24990391
[TBL] [Abstract][Full Text] [Related]
14. Desmopressin melt improves response and compliance compared with tablet in treatment of primary monosymptomatic nocturnal enuresis.
Juul KV; Van Herzeele C; De Bruyne P; Goble S; Walle JV; Nørgaard JP
Eur J Pediatr; 2013 Sep; 172(9):1235-42. PubMed ID: 23677249
[TBL] [Abstract][Full Text] [Related]
15. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
Van Herzeele C; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
[TBL] [Abstract][Full Text] [Related]
16. Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues.
Van de Walle J; Van Herzeele C; Raes A
Drug Saf; 2010 Apr; 33(4):261-71. PubMed ID: 20297859
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin 30 years in clinical use: a safety review.
Vande Walle J; Stockner M; Raes A; Nørgaard JP
Curr Drug Saf; 2007 Sep; 2(3):232-8. PubMed ID: 18690973
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and Pharmacodynamics of the Oral Disintegrating Tablet of Desmopressin in Adults with Nocturnal Polyuria: A Pilot Study.
Goessaert AS; Everaert K; Hoebeke P; Vande Walle J
Adv Ther; 2015 Sep; 32(9):799-808. PubMed ID: 26412224
[TBL] [Abstract][Full Text] [Related]
19. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
Robson WL; Leung AK; Norgaard JP
J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
[TBL] [Abstract][Full Text] [Related]
20. Safety profile of desmopressin tablet for enuresis in a prospective study.
Van Herzeele C; De Bruyne P; Evans J; Eggert P; Lottmann H; Norgaard JP; Vande Walle J
Adv Ther; 2014 Dec; 31(12):1306-16. PubMed ID: 25504157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
